South and Central America Drug Modelling Software Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product Type (Database, Software, and Others); and Application (Drug Discovery and Development, Computational Physiological Medicine, Disease Modelling, Medical Imaging, Predictive Analysis of Drug Targets, Simulation Software, Cellular Simulation, and Others)and Country
Market Introduction
Drug modelling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing key role in the development of novel drugs. Software based methods such as molecular modelling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. In addition, appropriate implementation of these techniques may help in reducing cost of drug designing and development.
Get more information on this report :
Market Overview and Dynamics
The South & Central America drug modelling software market is expected to reach US$ 606.80 million by 2027 from US$ 359.46 million in 2019. The market is anticipated to grow at a CAGR of 7.1% during 2019–2027. The increasing adoption of in-silico modelling tools in drug discovery, and increasing economic burden of drug discovery are the major factors expected to boost the growth of the drug modelling software market in South & Central America. However, the market is likely to get impacted by the risk factor such as less adoption in emerging countries during the forecast period.
Key Market Segments
In terms of product type, the software segment accounted for the largest share of the South & Central America drug modelling software market in 2019. In terms of application, drug discovery and development segment accounted for the largest share of the South & Central America drug modelling software market in 2019.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the South & Central America drug modelling software market report are the COVID-19 Command and Control Centre (CCC), World Health Organization (WHO), and others.
Reasons to buy report
- It provides understanding of the South & Central America, drug modelling software market landscape and identifies drug modelling software market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the South & Central America drug modelling software market.
- It helps efficiently plan merger and acquisition, and partnership deals in the drug modelling software market by identifying market segments with the most promising probable sales
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of drug modelling software market performance of various segments pertaining to the South & Central America drug modelling software market.
- It provides drug modelling software market revenue forecast of the market based on various segments for the period from 2019 to 2027.
SOUTH & CENTRAL AMERICA DRUG MODELLING SOFTWARE MARKET SEGMENTATION
By Product Type
- Database
- Software
- Others
By Application
- Drug Discovery and Development
- Computational Physiological Medicine
- Disease Modelling
- Medical Imaging
- Predictive Analysis of Drug Targets
- Simulation Software
- Cellular Simulation
- Others
By Country
- Brazil
- Argentina
- Rest of South & Central America
Company Profiles
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Drug Modelling Software Market – By Product Type
1.3.2 South & Central America Drug Modelling Software Market – By Application
1.3.3 South & Central America Drug Modelling Software Market – By Country
2. South & Central America Drug Modelling Software Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Drug Modelling Software Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Drug Modelling Software Market - South & Central America PEST Analysis
4.3 Expert Opinion
5. South & Central America Drug Modelling Software Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Adoption of Modelling Tools in Drug Discovery
5.1.2 Increasing Economic Burden of Drug Discovery
5.2 Key Market Restraints
5.2.1 Less Adoption in Emerging Countries
5.3 Key Market Opportunities
5.3.1 Strategic Activities by Market Players
5.4 Future Trends
5.4.1 Growing Adoption of Artificial Intelligence in Drug Discovery
5.5 Impact analysis
6. Drug Modelling Software Market – South & Central America Analysis
6.1 South & Central America Drug Modelling Software Market Revenue Forecasts and Analysis
7. South & Central America Drug Modelling Software Market Analysis and Forecasts To 2027 – By Product Type
7.1 Overview
7.2 South & Central America Drug Modelling Software Market, By Product Type 2019 & 2027 (%)
7.2.1 South & Central America Drug Modelling Software Market Revenue and Forecasts to 2027, By Product Type (US$ Mn)
7.3 Database
7.3.1 Overview
7.3.2 South & Central America Database Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Software
7.4.1 Overview
7.4.1.1 South & Central America Software Revenue and Forecasts to 2027 (US$ Mn)
7.5 Other Product Types
7.5.1 Overview
7.5.2 South & Central America Other Product Types Market Revenue and Forecast to 2027 (US$ Mn)
8. South & Central America Drug Modelling Software Market Analysis and Forecasts To 2027 – By Application
8.1 Overview
8.2 South & Central America Drug Modelling Software Market, By Application 2019 & 2027 (%)
8.2.1 South & Central America Drug Modelling Software Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Drug Discovery and Development
8.3.1 Overview
8.3.2 South & Central America Drug Discovery and Development Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Computational Physiological Medicine
8.4.1 Overview
8.4.2 South & Central America Computational Physiological Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Disease Modelling
8.5.1 Overview
8.5.2 South & Central America Disease Modelling Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Medical Imaging
8.6.1 Overview
8.6.2 South & Central America Medical Imaging Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Predictive Analysis of Drug Targets
8.7.1 Overview
8.7.2 South & Central America Predictive Analysis of Drug Targets Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Simulation Software
8.8.1 Overview
8.8.2 South & Central America Simulation Software Market Revenue and Forecasts to 2027 (US$ Mn)
8.9 Cellular Simulation
8.9.1 Overview
8.9.2 South & Central America Cellular Simulation Market Revenue and Forecasts to 2027 (US$ Mn)
8.10 Others
8.10.1 Overview
8.10.2 South & Central America Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Drug Modelling Software Market Revenue and Forecasts To 2027 – Geographical Analysis
9.1 South & Central America Drug modelling software Market Revenue and Forecasts To 2027
9.1.1 Overview
9.1.2 South & Central America: Drug Modelling Software Market - Revenue and Forecast to 2027 (US$ Million)
9.1.3 South & Central America Drug Modelling Software Market, by Product Type– Revenue and Forecast to 2027 (USD Million)
9.1.4 South & Central America Drug Modelling Software Market, by Application– Revenue and Forecast to 2027 (USD Million)
9.1.5 South & Central America: Drug Modelling Software Market, by Country, 2018 & 2027 (%)
9.1.6 Brazil: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 Brazil: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 Brazil Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
9.1.6.3 Brazil Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
9.1.7 UAE: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 UAE: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 UAE Drug Modelling Software Market, by Product Type– Revenue and Forecast to 2027 (USD Million)
9.1.7.3 UAE Drug Modelling Software Market, by Product Type– Revenue and Forecast to 2027 (USD Million)
9.1.8 South Africa: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 South Africa: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 South Africa Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
9.1.8.3 South Africa Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
10. Impact of COVID-19 Pandemic on South & Central America Drug Modelling Software Market
10.1 South & Central America: Impact Assessment of COVID-19 Pandemic
11. Company Profiles
11.1 Compugen Ltd.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Biognos AB
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Dassault Systèmes
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Acellera
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.5 Crown Bioscience Inc (JSR life science)
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
12. Appendix
12.1 About the Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. South & Central America Drug Modelling Software Market Revenue and Forecasts To 2027, By Product Type (US$ Mn)
Table 2. South & Central America Drug Modelling Software Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. South & Central America Drug Modelling Software Market, by Product Type– Revenue and Forecast to 2027 (USD Million)
Table 4. South & Central America Drug Modelling Software Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 5. Brazil Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 6. Brazil Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 7. UAE Drug Modelling Software Market, by Product Type– Revenue and Forecast to 2027 (USD Million)
Table 8. UAE Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. South Africa Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 10. South Africa Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 11. Glossary of Terms, Drug Modelling Software Market
LIST OF FIGURES
Figure 1. Drug Modelling Software Market Segmentation
Figure 2. South & Central America Drug Modelling Software Market Overview
Figure 3. Software Segment Held Largest Share of Drug Modelling Software Market
Figure 4. Brazil is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. South & Central America Drug Modelling Software Market - Leading Country Markets (US$ Mn)
Figure 6. Drug Modelling Software Market - South & Central America PEST Analysis
Figure 7. Drug Modelling Software Market Impact Analysis of Driver and Restraints
Figure 8. South & Central America Drug Modelling Software Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. South & Central America Drug Modelling Software Market, By Product Type 2019 & 2027 (%)
Figure 10. South & Central America Database Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. South & Central America Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. South & Central America Other Product Types Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. South & Central America Drug Modelling Software Market, By Application 2019 & 2027 (%)
Figure 14. South & Central America Drug Discovery and Development Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. South & Central America Computational Physiological Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. South & Central America Disease Modelling Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. South & Central America Medical Imaging Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. South & Central America Predictive Analysis of Drug Targets Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. South & Central America Simulation Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. South & Central America Cellular Simulation Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. South & Central America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. South & Central America: Drug Modelling Software Market, by Key Country – Revenue (2019) (USD Million)
Figure 23. South & Central America Drug Modelling Software Market Revenue and Forecast to 2027 (USD Million)
Figure 24. South & Central America: Drug Modelling Software Market, by Country, 2018 & 2027 (%)
Figure 25. Brazil: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
Figure 26. UAE: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. South Africa: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Impact of COVID-19 Pandemic in South & Central America Country Markets
- Crown Bioscience Inc (JSR life science)
- Compugen Ltd.
- Biognos AB
- Dassault Systèmes
- Acellera
- It provides understanding of the South & Central America, drug modelling software market landscape and identifies drug modelling software market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the South & Central America drug modelling software market.
- It helps efficiently plan merger and acquisition, and partnership deals in the drug modelling software market by identifying market segments with the most promising probable sales
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of drug modelling software market performance of various segments pertaining to the South & Central America drug modelling software market.
- It provides drug modelling software market revenue forecast of the market based on various segments for the period from 2019 to 2027.